AzTrials
AzTrials

ContraceptionNCT06081842

Strengthening Contraceptive Counseling Services: Research Protocol for a Multi-phase Complex Intervention in Pakistan and Nigeria

A study testing Contraceptive counseling strengthening intervention package in people with Contraception and Empowerment, run by World Health Organization.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

High-quality contraceptive counseling can strengthen global efforts to reduce the unmet need for and suboptimal use of modern contraceptives. This study aims to identify a package of contraceptive counseling interventions for Pakistan and Nigeria designed to strengthen existing contraceptive services and determine its… Read more about this study

Who is it for?
Ages 15 to 49 years, women onlyHealthy volunteers can take part
Conditions the study is for
Contraception, Empowerment, Decision Making
What is being tested?
Contraceptive counseling strengthening intervention package
Could I receive a placebo?
No, everyone receives an active treatment
How many people
7,920 participants
Where
No sites listed yet
Study dates
Nov 2023to Jun 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 15 to 49 years
  • Women only
  • Healthy volunteers accepted
  • Child, Adult

Who may be able to join

  • Client comes to the family planning clinic with the intention to 1.a. use contraception for the first time in her life (new user), or 1.b. switch from a contraceptive method to another one (switching user), or 1.c. resume a method after not using any in the prior three months (lapse user), or 1.d. discontinue a modern method (discontinuing user);
  • Client is not coming for the resupply of a currently used method, such as pills or injectables;
  • Client has the intention to continue her follow-up at the health center during the duration of study follow-up;
  • Client does not participate in another study; and
  • Client provides informed consent.

Who cannot join

  • Not willing to participate in the complete duration of the trial

About this study

Official title: Strengthening Contraceptive Counseling Services, a Multi-country Study Trial

High-quality contraceptive counseling can strengthen global efforts to reduce the unmet need for and suboptimal use of modern contraceptives. This study aims to identify a package of contraceptive counseling interventions for Pakistan and Nigeria designed to strengthen existing contraceptive services and determine its effectiveness in increasing clients' level of decision-making autonomy and meeting their contraceptive needs.

Read the detailed description

The research will be a multi-intervention, three-arm, single-blinded, parallel, cluster RCT done in selected primary health centers (clusters) in Pakistan and in Nigeria. Centers will be randomly allocated to the three study arms in matched ratios (1:1:1) on the basis of the number of monthly family planning encounters, the number of available contraceptive types, the ratio of health workers per population in the clinic coverage zone, the location in urban or rural settings, and selected district-level variables that may have an influence on the study outcomes, including the unmet need for family planning, the level of literacy among women, and household income quartiles. Only data analysts will be masked to trial-arm allocation. Service providers skilled in family planning services will implement the clinical components of the contraceptive counseling package. The cluster RCT design is justified by the fact that some of the components of the intervention package to be identified in the intervention design phase will not be delivered directly to individual participants but only applied at the level of the health center, such as refresher training of service providers.

The two-part formative phase first uses participatory approaches to identify the perspectives of clients, including young people and providers, to ensure research contextualization and address each interest group's needs and priorities; clinical observations of client-provider encounters to document routine care form the second part. The design workshop of the third phase will result in the development of a package of contraceptive counseling interventions. In the fourth and experimental phase, a multi-intervention, three-arm, single-blinded, parallel cluster randomized-controlled trial will compare routine care (arm 1) with the contraceptive counseling package (arm 2) and the same package combined with wider method availability (arm 3). The fifth and reflective phase aims to analyze the package's cost-effectiveness and identify implementation barriers and enablers. The primary outcomes are clients' level of decision-making autonomy and met need for modern contraceptives.

Being tested
Contraceptive counseling strengthening intervention package
Keywords
Family Planning, Counselling, choice
Medical subject headings
Empowerment

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Contraceptive counseling strengthening intervention packageOther

    Development of contraceptive counseling strengthening intervention package that strengthens existing family planning services and is effective, safe, sustainable, scalable, and culturally appropriate.

Study groups in NCT06081842
Study groupRoleWhat they receive
Arm 1. Routine careActive comparatorRoutine contraceptive counseling and routine method availability
Receives: Other: Contraceptive counseling strengthening intervention package
Arm 2. Package of contraceptive counseling interventionsExperimentalThe implementation package will be co-designed by providers and clients during the formative and research design phases
Receives: Other: Contraceptive counseling strengthening intervention package
Arm 3. Expanded methodsExperimentalRoutine care with the contraceptive counseling package combined with wider method availability as recommended by national policies.
Receives: Other: Contraceptive counseling strengthening intervention package

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in clients' decision-making autonomy

    Person-Centered Contraceptive Counseling scale (PCCC). On a scale of 1-5, with score range between 4 to a maximum score of 20, with the highest possible score on a scale will be considered good.

    Measured: Through study completion, an average of 1 year

  2. Change in clients' met need for family planning

    Number of participants who want to avoid a pregnancy and are using a contraceptive method / all participants

    Measured: Through study completion, an average of 1 year

Secondary outcomes (1)
  1. Change in modern contraceptive prevalence

    Number of participants using a modern contraceptive / all participants

    Measured: 6 months and 12 months post enrollment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Oct 2023
  2. Study startNov 2023 (estimated)
  3. Primary completionNov 2025 (estimated)
  4. Study completionJun 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Model description
The research entails a complex multi-site, two-stage and 5-phase: STAGE 1 is formative and will comprise of a pre-formative (phase 1) and a formative (phase 2). While the STAGE 2 is experimental and will include intervention design (phase 3), experimental (phase 4), and reflective (phase 5).
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
7,920 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06081842
Sponsor's protocol ID
WHO
Status last verified
Oct 2023
First submitted
18 Sep 2023
Last updated
13 Oct 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: (i) use of a controlled access approach, such as upon reasonable request from the World Health Organization; (ii) the trial will seek consent for sharing Individual Participant Data (IPD) from trial participants with adequate assurance that patient privacy and confidentiality will be maintained

Publications

  • Azmat SK, Awan MA, Thom EM, Uzma Q, Sheikh I, Kapustianyk G, Kiarie J, Ali M. Closing the counselling gap: a qualitative study to strengthen rights-based family planning in Pakistan. BMJ Open. 2026 Aug 24;16(8):e116059. doi: 10.1136/bmjopen-2025-116059.

    PubMed 42637256
  • Tran NT, Ali M, Azmat SK, Seuc A, Olaolorun FM, Awan MA, Morhason-Bello I, Thom EM, Martin J, Abubakar HD, Uzma Q, Kiarie J. Strengthening contraceptive counselling services to empower clients and meet their needs: protocol for a two-stage, multiphase complex intervention in Pakistan and Nigeria. BMJ Open. 2024 Jun 5;14(6):e081967. doi: 10.1136/bmjopen-2023-081967.

    PubMed 38839392

Questions about this trial

What is this clinical trial studying?

A study testing Contraceptive counseling strengthening intervention package in people with Contraception and Empowerment, run by World Health Organization.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 13 Oct 2023. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in clients' decision-making autonomy (time frame: Through study completion, an average of 1 year). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06081842, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Oct 2023; AzTrials last refreshed its copy on 1 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in